
Sign up to save your podcasts
Or
Dr. Guymer discusses the results of the FLUID study which investigated whether some residual sub retinal fluid can be tolerated in neovascular macular degeneration.
Full reference:
Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen. Guymer, Robyn H.Chang, Andrew et al. Ophthalmology, Volume 126, Issue 5, 723 - 734
4.4
1111 ratings
Dr. Guymer discusses the results of the FLUID study which investigated whether some residual sub retinal fluid can be tolerated in neovascular macular degeneration.
Full reference:
Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen. Guymer, Robyn H.Chang, Andrew et al. Ophthalmology, Volume 126, Issue 5, 723 - 734
43 Listeners
17 Listeners
5 Listeners
442 Listeners
20 Listeners
10 Listeners
50 Listeners
10 Listeners
1 Listeners
18 Listeners
16 Listeners
0 Listeners
16 Listeners
0 Listeners
0 Listeners